Marek David C
Principal Executive Officer at Myovant Sciences Ltd.
- Sold, on record
- $1.2M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jan 18, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Myovant Sciences Ltd.Principal Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Myovant Sciences Ltd.Plan not statedJan 19, 2022 2022
Sold 19,882 shares at $14.68 ($292k)
Marek David C, Principal Executive Officer
Sold 5.6% of holdings ($5.3M position)337,983 shares leftFirst sale on recordFiling
- 2 Form 4 sale Myovant Sciences Ltd.Plan not statedApr 19, 2022 +90 days
Sold 24,594 shares at $10.45 ($257k)
Marek David C, Principal Executive Officer
Sold 5.2% of holdings ($4.9M position)447,956 shares leftFiling
- 3 Form 4 sale Myovant Sciences Ltd.Plan not statedJul 18, 2022 +90 days
Sold 11,164 shares at $12.87 ($144k)
Marek David C, Principal Executive Officer
Sold 2.5% of holdings ($5.8M position)436,792 shares leftFiling
- 4 Form 4 sale Myovant Sciences Ltd.Plan not statedOct 18, 2022 +92 days
Sold 11,156 shares at $25.20 ($281k)
Marek David C, Principal Executive Officer
Sold 2.6% of holdings ($11M position)425,636 shares left0.6x usual sizeFiling
- 5 Form 4 sale Myovant Sciences Ltd.Plan not statedJan 18, 2023 +92 days
Sold 8,037 shares at $26.89 ($216k)
Marek David C, Principal Executive Officer
Sold 1.9% of holdings ($11.4M position)417,599 shares left0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | Jan 20, 2023 | Myovant Sciences Ltd. | Principal Executive Officer | Form 4 sale | 8,037 | $216k | 1.9% | Plan not stated | SEC |
| Oct 18, 2022 | Oct 20, 2022 | Myovant Sciences Ltd. | Principal Executive Officer | Form 4 sale | 11,156 | $281k | 2.6% | Plan not stated | SEC |
| Jul 18, 2022 | Jul 20, 2022 | Myovant Sciences Ltd. | Principal Executive Officer | Form 4 sale | 11,164 | $144k | 2.5% | Plan not stated | SEC |
| Apr 19, 2022 | Apr 21, 2022 | Myovant Sciences Ltd. | Principal Executive Officer | Form 4 sale | 24,594 | $257k | 5.2% | Plan not stated | SEC |
| Jan 19, 2022 | Jan 21, 2022 | Myovant Sciences Ltd. | Principal Executive Officer | Form 4 sale | 19,882 | $292k | 5.6% | Plan not stated | SEC |